接受质子放疗时年龄小于4岁的儿童脑肿瘤幸存者的长期健康相关生活质量
本研究纳入2000至2011年间接受质子治疗的59例小于4岁脑肿瘤患儿,40个家庭参与,采用PedsQL核心量表评估长期健康相关生活质量。中位随访6.7年,患儿自评和家长代评的总核心得分分别为78.4和72.9。家长报告37.5%的患者生活质量落在健康儿童范围,45%落在严重健康状况儿童范围。
要点
- 三分之一幸存者的长期健康相关生活质量与健康儿童相当。
- 脑积水治疗或喂养管与显著较低的健康相关生活质量相关。
- 总核心健康相关生活质量得分从基线至末次随访保持稳定。
核心结论
- 在非常年幼时接受质子治疗的脑肿瘤幸存者中,长期健康相关生活质量存在差异,超过三分之一达到与健康儿童相当的水平。
研究设计与样本
- 2000至2011年间59例小于4岁儿童接受质子治疗,40个家庭参与,采用PedsQL核心量表进行儿童自评(年龄≥5岁)和家长代评(年龄2岁以上)。
主要发现
- 质子治疗时中位年龄2.5岁(范围0.3-3.8),末次随访时中位年龄9.1岁(5.5-18),中位随访6.7年(3-15.4)。
- 随访时儿童自评和家长代评平均得分:总核心78.4和72.9,躯体82.9和75.2,心理社会76.0和71.6,情绪74.4和70.7,社交81.2和75.1,学校72.4和69.9。
- 家长报告的健康相关生活质量落在既往定义的健康儿童范围者占37.5%,落在严重健康状况儿童范围者占45%。
- 除社交功能外,家长代评健康相关生活质量从基线至末次随访在所有领域保持稳定。
- 多变量分析中,胃造瘘管史与较差的儿童自评和家长代评健康相关生活质量显著相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this analysis is to report long-term health-related quality of life (HRQoL) among brain tumor survivors treated with proton therapy (PRT) at a very young age. METHODS: Fifty-nine children <4 years old received PRT between 2000 and 2011. Forty families participated. HRQoL was assessed by child self-report (CSR; age ≥5) and parent proxy report (PPR; age 2+) using the PedsQL Core. RESULTS: The median age was 2.5 years (range, 0.3-3.8) at PRT and 9.1 years (5.5-18) at last follow-up. The most common diagnoses were ependymoma (n = 22) and medulloblastoma (n = 7). Median follow-up is 6.7 years (3-15.4). Follow-up mean CSR and PPR scores were: total core (78.4 and 72.9), physical (82.9 and 75.2), psychosocial (76.0 and 71.6), emotional (74.4 and 70.7), social (81.2 and 75.1), and school (72.4 and 69.9). Parent-reported HRQoL fell within a previously defined range for healthy children in 37.5% of patients, and for children with severe health conditions in 45% of patients. PPR HRQoL was stable from baseline to last follow-up among all domains except for social functioning. History of gastrostomy tube was significantly associated with poorer CSR and PPR HRQoL on multivariable analysis. Ninety percent of children functioned in a regular classroom, 14 (36%) used a classroom aid, 9 (23%) used an outside tutor, and 18 (46%) had an individualized education plan. CONCLUSION: Long-term HRQoL among brain tumor survivors treated with PRT at a very young age is variable, with over a third achieving HRQoL levels commensurate with healthy children. KEY POINTS: 1. One third of survivors reported long-term HRQoL scores comparable to those of healthy children.2. Treatment for hydrocephalus or a feeding tube was associated with significantly lower HRQoL.3. Total core HRQoL scores remained stable from baseline to last follow-up.
引用
- Eaton BR, Goldberg S, Tarbell NJ, et al. Long-term health-related quality of life in pediatric brain tumor survivors receiving proton radiotherapy at <4 years of age. Neuro Oncol. 2020. PMID: 32064512. doi:10.1093/neuonc/noaa042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。